Agilent Technologies has a long history of building nucleic acids. Originating through Agilent’s spin-off from Hewlett-Packard Company, our DNA oligonucleotide synthesis technology is based on the concepts that enable ink-jet printing. This platform empowers the printing of up to a million oligo features on a single chip, creating highly complex oligo pools with each oligo present in precise ratios. The advanced chemistries developed at Agilent also enables the printing of longer oligos than are typically available from commercial suppliers. We have harnessed this technology to develop a wide range of market-leading products including SurePrint custom microarrays, SureSelect for NGS target enrichment, SureFISH probes, and the QuikChange HT mutagenesis kit for protein engineering. Whether you are looking for the highest quality pre-defined content or you need to create your oligo libraries from the ground-up, Agilent has a solution for your CRISPR needs.
Swing by our booth from June 22-26, 2020 during the SEED conference at the Hyatt Regency, San Francisco. Learn everything there is to know on the newest advancements in synthetic biology. Come and discuss your CRISPR needs with our experts!
From May 11th to 14th 2020, you can find us at our booth during TIDES at the Hynes Convention Center, Boston. Looking for some expert advice to conduct successful CRISPR and oligo-experiments in your lab? Come talk to us!